Inactief instrument

Andere talen Zymeworks Inc. Toronto S.E.

Aandelen

ZYME

CA98985W1023

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Zymeworks Announces Participation in Upcoming Investor Conferences	28/05
Kirby McInerney LLP is Investigating Potential Shareholder Claims Against Zymeworks Inc. (ZYME)	16/05
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME	07/05
Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results	02/05
Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results	02/05
Zymeworks Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05
Unlocking the potential of antibody drug conjugates	01/05
Zymeworks Announces Participation in Upcoming Investor Conferences	30/04
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME	28/04
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME	20/04
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME	12/04
Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024	11/04
Zymeworks Inc. Presents New Data from Multiple Preclinical Development Programs At 2024 American Association for Cancer Research Annual Meeting	08/04
Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting	08/04
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME	05/04
Zymeworks Inc. Removes Christopher Astle from the Positions of Chief Financial Officer	04/04
Zymeworks Inc. Removes Dr. Christopher Astle from the Positions of Senior Vice President	04/04
Zymeworks Inc. Announces the Composition of the Committees	28/03
Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors	28/03
Zymeworks Inc. Announces Appointment of Neil Gallagher to Its Board of Directors and as Member of the Research and Development Committee, Effective April 2, 2024	28/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Zymeworks Inc. Toronto S.E.

Aandelen

ZYME

CA98985W1023

Andere talen

Filters